Norris Medicines Ltd.

Financial

	Norris Medicines	Parmax Pharma	Colinz Laboratories
Operational Metrics
Financials
5 yr Average ROE	47.03 %	-1624.87 %	4.05 %
5yr average Equity Multiplier	-2.46	46.04	1.3
5yr Average Asset Turnover Ratio	0.6	0.95	0.7
5yr Avg Net Profit Margin	-30.66 %	-9.48 %	4.66 %
Price to Book	0.0	0.0	1.6
P/E	0.0	0.0	31.43
5yr Avg Cash Conversion Cycle	97.28 Days	-161.05 Days	-0.66 Days
Inventory Days	165.43 Days	73.65 Days	64.79 Days
Days Receivable	69.98 Days	40.27 Days	51.75 Days
Days Payable	260.51 Days	328.05 Days	78.66 Days
5yr Average Interest Coverage Ratio	-1.37	1.16	9.16
5yr Avg ROCE	-19.87 %	-9.94 %	6.01 %
5yr Avg Operating Profit Margin	-6.94 %	3.93 %	6.82 %
5 yr average Debt to Equity	-3.0	17.42	0.07
5yr CAGR Net Profit	-15.97 %	n/a	30.39 %
5yr Average Return on Assets	-18.92 %	-6.43 %	3.14 %
Shareholdings
Promoter Holding	34.0 %	30.8 %	65.94 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.04 %	0.0	29.56 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0